Product Images Divalproex Sodium ER

This appears to be a table that shows the percentage reduction in CPS (cycles per second) rate for patients taking Divalproex Sodium Delayed-Release Tablets versus a placebo. The table also indicates the percentage of patients who experienced improvement, no change, or worsening of symptoms.*

This text appears to be a comparison chart between high dose and low dose Divalproex Sodium Delayed-Release Tablets in terms of reduction in CPS Rate. The chart shows that 50% of patients experienced improvement, while some experienced worsening or no change. However, without context, it is difficult to determine the significance of these findings.*

The text is not-available.*

This is a description of a medication bottle of Divalproex Sodium Extended-Release Tablets. The bottle contains 100 tablets, and the dosage instructions suggest taking one tablet per day. The tablets are 250 mg each and should be dispensed with a medication guide provided separately. The bottle should not be accepted if the seal is broken or missing, and it should be stored at a temperature between 20-25°C (68-77°F) in a light-resistant container. A pharmacist should dispense this medication in a USP-controlled room temperature.*

This is a medication with the identification code NDC 64676:725-02. It is a Divalproex Sodium Extended-Release Tablet with once-daily dosage. Each tablet contains 500 mg of Divalproex sodium equivalent to valproic acid. It is advised to not to use if seal over bottle opening is broken or missing. The usual dosage instructions are provided in the package insert. It needs to be dispensed in a USP tight light-resistant container. The size of the tablet is 55 mm x 20 mm and it comes in a bottle of 100 tablets. The manufacturer of this tablet is not mentioned, but it is distributed by Wodbar U Vockhat USALL.*

This is a pharmaceutical product containing Divalproex Sodium Extended-Release tablets and Valproic Acid in USP grade. It is available in the form of tablets and is recommended for use under the supervision of a pharmacist. No other useful description could be generated due to the limited and incomplete information available.*

This is a description of a medication with the NDC 64679.725.01. The medication is Divalproex Sodium Extended-Release Tablets, USP which are taken once a day. The usual dosage is specified on the package and it contains Valproic Acid. The medication has been prescribed by a doctor and must be dispensed by a pharmacist. There are 30 tablets in the package to be stored at 20-25 C.*

This is a description for Divalproex Sodium Extended-Release Tablets, USP used for once-daily dosing. The tablets come in a bottle with 500mg strength and should be dispensed with a medication guide provided separately. Don't accept the bottle if the seal is broken or missing. The usual dosage should be followed as per package insert or prescribing information. The tablets should be stored in a USP tight, heat-resistant container between 20-25°C. This medication is Rxonly and is manufactured by Workna Lo. The contact details for the manufacturer and distributor are provided.*